NewslettersImmune Regulation NewsProstate Cell NewsIL-15 and Anti-PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 TumorsBy Justin.choi - March 11, 2022019Researchers investigated the combination of IL-15 with an intratumoral anti-CD40 monoclonal antibody (mAb) in a dual tumor TRAMP-C2 murine prostate cancer model and expanded the regimen to include an anti-PD-1 mAb.[Clinical Cancer Research] 6445212 AAAAAAAA items 1 apa 0 default asc 1 172753 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract